Childhood maltreatment severity is associated with elevated C-reactive protein and body mass index in adults with schizophrenia and bipolar diagnoses

Brain, Behavior, and Immunity

Volumn 65, Issue , 2017, Pages 342-349

  Aas, Monica ^a   Dieset, Ingrid ^a   Hope, Sigrun ^a   Hoseth, Eva ^a   Mørch, Ragni ^a   Reponen, Elina ^a   Steen, Nils Eiel ^a,b   Laskemoen, Jannicke Fjæra ^a   Ueland, Thor ^c,d   Aukrust, Pål ^c,d   Agartz, Ingrid ^a,e,f   Andreassen, Ole A ^a   Melle, Ingrid ^a  

^a Institute of Clinical Medicine   (Norway)

^b VESTRE VIKEN HOSPITAL TRUST   (Norway)

^c OSLO UNIVERSITY HOSPITAL   (Norway)

^d UNIVERSITY OF OSLO   (Norway)

^e DIAKONHJEMMET HOSPITAL   (Norway)

^f KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Bipolar disorders; BMI; Childhood trauma; Inflammation; Schizophrenia

Indexed keywords

ANTIDEPRESSANT AGENT; BIOLOGICAL MARKER; C REACTIVE PROTEIN; GLYCOPROTEIN GP 130; NEUROLEPTIC AGENT; TUMOR NECROSIS FACTOR RECEPTOR 1;

ADULT; AGED; ARTICLE; BIPOLAR DISORDER; BODY MASS; CHILD ABUSE; CHILDHOOD; CHILDHOOD TRAUMA QUESTIONNAIRE; CONTROLLED STUDY; DISEASE ASSOCIATION; DSM-IV; EMOTIONAL ABUSE; FEMALE; HUMAN; IMMUNE RESPONSE; MAJOR CLINICAL STUDY; MALE; PHYSICAL ABUSE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SCHIZOPHRENIA; SEXUAL ABUSE; STRUCTURED CLINICAL INTERVIEW FOR DSM DISORDERS; BLOOD; CASE CONTROL STUDY; CHILD; COMPLICATION; INFLAMMATION; METABOLISM; OBESITY; PSYCHOLOGY; PSYCHOSIS;

ADULT; BIOMARKERS; BIPOLAR DISORDER; BODY MASS INDEX; C-REACTIVE PROTEIN; CASE-CONTROL STUDIES; CHILD; CHILD ABUSE; CYTOKINE RECEPTOR GP130; FEMALE; HUMANS; INFLAMMATION; MALE; OBESITY; PSYCHOTIC DISORDERS; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE I; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY;

EID: 85020930235     PISSN: 08891591     EISSN: 10902139     Source Type: Journal    
DOI: 10.1016/j.bbi.2017.06.005     Document Type: Article

References (50)

1. Aas, M., Etain, B., Bellivier, F., Henry, C., Lagerberg, T., Ringen, A., Agartz, I., Gard, S., Kahn, J.P., Leboyer, M., Andreassen, O.A., Melle, I., Additive effects of childhood abuse and cannabis abuse on clinical expressions of bipolar disorders. Psychol. Med. 44 (2014), 1653–1662.
2. Aas, M., Haukvik, U.K., Djurovic, S., Tesli, M., Athanasiu, L., Bjella, T., Hansson, L., Cattaneo, A., Agartz, I., Andreassen, O.A., Melle, I., Interplay between childhood trauma and BDNF val66met variants on blood BDNF mRNA levels and on hippocampus subfields volumes in schizophrenia spectrum and bipolar disorders. J. Psychiatr. Res. 59 (2014), 14–21.
3. Aas, M., Andreassen, O.A., Aminoff, S.R., Faerden, A., Romm, K.L., Nesvag, R., Berg, A.O., Simonsen, C., Agartz, I., Melle, I., A history of childhood trauma is associated with slower improvement rates: findings from a one-year follow-up study of patients with a first-episode psychosis. BMC. Psychiatry, 16, 2016, 126.
4. Banks, W.A., Erickson, M.A., The blood-brain barrier and immune function and dysfunction. Neurobiol. Dis. 37 (2010), 26–32.
5. Baumeister, D., Akhtar, R., Ciufolini, S., Pariante, C.M., Mondelli, V., Childhood trauma and adulthood inflammation: a meta-analysis of peripheral C-reactive protein, interleukin-6 and tumour necrosis factor-alpha. Mol. Psychiatry 21 (2015), 642–649.
6. Bernstein, D.P., Fink, L., Handelsman, L., Foote, J., Lovejoy, M., Wenzel, K., Sapareto, E., Ruggiero, J., Initial reliability and validity of a new retrospective measure of child abuse and neglect. Am. J. Psychiatry 151 (1994), 1132–1136.
7. Beumer, W., Gibney, S.M., Drexhage, R.C., Pont-Lezica, L., Doorduin, J., Klein, H.C., Steiner, J., Connor, T.J., Harkin, A., Versnel, M.A., Drexhage, H.A., The immune theory of psychiatric diseases: a key role for activated microglia and circulating monocytes. J. Leukoc. Biol. 92 (2012), 959–975.
8. Brown, A.S., The environment and susceptibility to schizophrenia. Prog. Neurobiol. 93 (2011), 23–58.
9. Brown, A.S., The Kraepelinian dichotomy from the perspective of prenatal infectious and immunologic insults. Schizophr. Bull. 41 (2015), 786–791.
10. Coelho, R., Viola, T.W., Walss-Bass, C., Brietzke, E., Grassi-Oliveira, R., Childhood maltreatment and inflammatory markers: a systematic review. Acta Psychiatr. Scand. 129 (2014), 180–192.
11. Cohen, J., Statistical Power Analysis for the Behavioral Sciences. 1977, Academic Press, New York.
12. Coodin, S., Body mass index in persons with schizophrenia. Can. J. Psychiatry 46 (2001), 549–555.
13. Craddock, N., Owen, M.J., The Kraepelinian dichotomy - going, going… but still not gone. Br. J. Psychiatry 196 (2010), 92–95.
14. Craddock, N., O'Donovan, M.C., Owen, M.J., Psychosis genetics: modeling the relationship between schizophrenia, bipolar disorder, and mixed (or “schizoaffective”) psychoses. Schizophr. Bull. 35 (2009), 482–490.
15. Danese, A., Tan, M., Childhood maltreatment and obesity: systematic review and meta-analysis. Mol. Psychiatry 19 (2014), 544–554.
16. Danese, A., Pariante, C.M., Caspi, A., Taylor, A., Poulton, R., Childhood maltreatment predicts adult inflammation in a life-course study. Proc. Natl. Acad. Sci. U. S. A 104 (2007), 1319–1324.
17. Danese, A., Moffitt, T.E., Pariante, C.M., Ambler, A., Poulton, R., Caspi, A., Elevated inflammation levels in depressed adults with a history of childhood maltreatment. Arch. Gen. Psychiatry 65 (2008), 409–415.
18. Danese, A., Lewis, S.J., Psychoneuroimmunology of early-life stress: the hidden wounds of childhood trauma?. Neuropsychopharmacology. 42 (2017), 99–114.
19. Dantzer, R., O'Connor, J.C., Freund, G.G., Johnson, R.W., Kelley, K.W., From inflammation to sickness and depression: when the immune system subjugates the brain. Nat. Rev. Neurosci. 9 (2008), 46–56.
20. Dennison, U., McKernan, D., Cryan, J., Dinan, T., Schizophrenia patients with a history of childhood trauma have a pro-inflammatory phenotype. Psychol. Med. 42 (2012), 1865–1871.
21. Dieset, I., Djurovic, S., Tesli, M., Hope, S., Mattingsdal, M., Michelsen, A., Joa, I., Larsen, T.K., Agartz, I., Melle, I., Rossberg, J.I., Aukrust, P., Andreassen, O.A., Ueland, T., Up-regulation of NOTCH4 gene expression in bipolar disorder. Am. J. Psychiatry 169 (2012), 1292–1300.
22. Dieset, I., Hope, S., Ueland, T., Bjella, T., Agartz, I., Melle, I., Aukrust, P., Rossberg, J.I., Andreassen, O.A., Cardiovascular risk factors during second generation antipsychotic treatment are associated with increased C-reactive protein. Schizophr. Res. 140 (2012), 169–174.
23. Dieset, I., Andreassen, O.A., Haukvik, U.K., Somatic comorbidity in schizophrenia: some possible biological mechanisms across the life span. Schizophr. Bull. 42 (2016), 1316–1319.
24. Elenkov, I.J., Webster, E.L., Torpy, D.J., Chrousos, G.P., Stress, corticotropin-releasing hormone, glucocorticoids, and the immune/inflammatory response: acute and chronic effects. Ann. N. Y. Acad. Sci. 876 (1999), 1–11.
25. Etain, B., Henry, C., Bellivier, F., Mathieu, F., Leboyer, M., Beyond genetics: childhood affective trauma in bipolar disorder. Bipolar Disord. 10 (2008), 867–876.
26. Etain, B., Aas, M., Andreassen, O.A., Lorentzen, S., Dieset, I., Gard, S., Kahn, J.P., Bellivier, F., Leboyer, M., Melle, I., Henry, C., Childhood trauma is associated with severe clinical characteristics of bipolar disorders. J. Clin. Psychiatry 74 (2013), 991–998.
27. Festa, A., D'Agostino, R. Jr., Williams, K., Karter, A.J., Mayer-Davis, E.J., Tracy, R.P., Haffner, S.M., The relation of body fat mass and distribution to markers of chronic inflammation. Int. J. Obes. Relat. Metab. Disord. 25 (2001), 1407–1415.
28. Fillman, S.G., Sinclair, D., Fung, S.J., Webster, M.J., Shannon, W.C., Markers of inflammation and stress distinguish subsets of individuals with schizophrenia and bipolar disorder. Transl. Psychiatry, 4, 2014, e365.
29. Fisher, H.L., Craig, T.K., Fearon, P., Morgan, K., Dazzan, P., Lappin, J., Hutchinson, G., Doody, G.A., Jones, P.B., McGuffin, P., Murray, R.M., Leff, J., Morgan, C., Reliability and comparability of psychosis patients' retrospective reports of childhood abuse. Schizophr. Bull. 37 (2011), 546–553.
30. Giovanoli, S., Engler, H., Engler, A., Richetto, J., Voget, M., Willi, R., Winter, C., Riva, M.A., Mortensen, P.B., Feldon, J., Schedlowski, M., Meyer, U., Stress in puberty unmasks latent neuropathological consequences of prenatal immune activation in mice. Science 339 (2013), 1095–1099.
31. Hepgul, N., Pariante, C.M., Dipasquale, S., DiForti, M., Taylor, H., Marques, T.R., Morgan, C., Dazzan, P., Murray, R.M., Mondelli, V., Childhood maltreatment is associated with increased body mass index and increased C-reactive protein levels in first-episode psychosis patients. Psychol. Med. 42 (2012), 1893–1901.
32. Hope, S., Melle, I., Aukrust, P., Steen, N.E., Birkenaes, A.B., Lorentzen, S., Agartz, I., Ueland, T., Andreassen, O.A., Similar immune profile in bipolar disorder and schizophrenia: selective increase in soluble tumor necrosis factor receptor I and von Willebrand factor. Bipolar Disord. 11 (2009), 726–734.
33. Kessing, L.V., Vradi, E., McIntyre, R.S., Andersen, P.K., Causes of decreased life expectancy over the life span in bipolar disorder. J. Affect. Disord. 180 (2015), 142–147.
34. Khandaker, G.M., Dantzer, R., Is there a role for immune-to-brain communication in schizophrenia?. Psychopharmacology 233 (2016), 1559–1573.
35. Larsson, S., Andreassen, O.A., Aas, M., Rossberg, J.I., Mork, E., Steen, N.E., Barrett, E.A., Lagerberg, T.V., Peleikis, D., Agartz, I., Melle, I., Lorentzen, S., High prevalence of childhood trauma in patients with schizophrenia spectrum and affective disorder. Compr. Psychiatry 54 (2013), 123–127.
36. Leboyer, M., Oliveira, J., Tamouza, R., Groc, L., Is it time for immunopsychiatry in psychotic disorders?. Psychopharmacology 233 (2016), 1651–1660.
37. MacDonald, K., Thomas, M.L., MacDonald, T.M., Sciolla, A.F., A perfect childhood? Clinical correlates of minimization and denial on the childhood trauma questionnaire. J. Interpers. Violence 30 (2015), 988–1009.
38. MacDonald, K., Thomas, M.L., Sciolla, A.F., Schneider, B., Pappas, K., Bleijenberg, G., Bohus, M., Bekh, B., Carpenter, L., Carr, A., Dannlowski, U., Dorahy, M., Fahlke, C., Finzi-Dottan, R., Karu, T., Gerdner, A., Glaesmer, H., Grabe, H.J., Heins, M., Kenny, D.T., Kim, D., Knoop, H., Lobbestael, J., Lochner, C., Lauritzen, G., Ravndal, E., Riggs, S., Sar, V., Schafer, I., Schlosser, N., Schwandt, M.L., Stein, M.B., Subic-Wrana, C., Vogel, M., Wingenfeld, K., Minimization of childhood maltreatment is common and consequential: results from a large, multinational sample using the childhood trauma questionnaire. PLoS One, 11, 2016, e0146058.
39. Meyer, U., Feldon, J., Yee, B.K., A review of the fetal brain cytokine imbalance hypothesis of schizophrenia. Schizophr. Bull. 35 (2009), 959–972.
40. Miller, A.H., Maletic, V., Raison, C.L., Inflammation and its discontents: the role of cytokines in the pathophysiology of major depression. Biol. Psychiatry 65 (2009), 732–741.
41. Mondelli, V., Dazzan, P., Hepgul, N., Di, F.M., Aas, M., D'Albenzio, A., Di, N.M., Fisher, H., Handley, R., Marques, T.R., Morgan, C., Navari, S., Taylor, H., Papadopoulos, A., Aitchison, K.J., Murray, R.M., Pariante, C.M., Abnormal cortisol levels during the day and cortisol awakening response in first-episode psychosis: the role of stress and of antipsychotic treatment. Schizophr. Res. 116 (2010), 234–242.
42. Morch, R.H., Dieset, I., Faerden, A., Hope, S., Aas, M., Nerhus, M., Gardsjord, E.S., Joa, I., Morken, G., Agartz, I., Aukrust, P., Djurovic, S., Melle, I., Ueland, T., Andreassen, O.A., Inflammatory evidence for the psychosis continuum model. Psychoneuroendocrinology 67 (2016), 189–197.
43. Noble, J.M., Manly, J.J., Schupf, N., Tang, M.X., Mayeux, R., Luchsinger, J.A., Association of C-reactive protein with cognitive impairment. Arch. Neurol. 67 (2010), 87–92.
44. Ribeiro-Santos, A., Lucio, T.A., Salgado, J.V., Evidence for an immune role on cognition in schizophrenia: a systematic review. Curr. Neuropharmacol. 12 (2014), 273–280.
45. Ripke, S., Sanders, A.R., Kendler, K.S., Levinson, D.F., Sklar, P., et al. Common variants conferring risk of schizophrenia. Nature 460 (2009), 744–747.
46. Schizophrenia Working Group of the Psychiatric Genomics Consortium, Biological insights from 108 schizophrenia-associated genetic loci. Nature 511 (2014), 421–427.
47. Schizophrenia Working Group of the Psychiatric Genomics Consortium, Psychiatric genome-wide association study analyses implicate neuronal, immune and histone pathways. Nat. Neurosci. 18 (2015), 199–209.
48. Siervo, M., Ruggiero, D., Sorice, R., Nutile, T., Aversano, M., Iafusco, M., Vetrano, F., Wells, J.C., Stephan, B.C., Ciullo, M., Body mass index is directly associated with biomarkers of angiogenesis and inflammation in children and adolescents. Nutrition 28 (2012), 262–266.
49. Stefansson, H., Ophoff, R.A., Steinberg, S., Andreassen, O.A., Cichon, S., Rujescu, D., et al. Common variants conferring risk of schizophrenia. Nature 460 (2009), 744–747.
50. Van Gaal, L.F., Mertens, I.L., De Block, C.E., Mechanisms linking obesity with cardiovascular disease. Nature 444 (2006), 875–880.